Demyelinating neuropathy and local toxicity caused by extravasated Brentuximab vedotin
Author:
Affiliation:
1. Department of Dermatology, Venereology and Allergology University Medical Center Göttingen Göttingen Germany
2. Department of Neurology University Medical Center Göttingen Göttingen Germany
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16502
Reference8 articles.
1. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
2. U.S. Food and Drug Adminstration.FDA approves Brentuximab vedotin for the treatment of adult patients with primary cutaneous anaplastic large cell lymphoma 2017. URLhttps://www.fda.gov/drugs/resources‐information‐approved‐drugs/fda‐approves‐brentuximab‐vedotin‐treatment‐adult‐patients‐primary‐cutaneous‐anaplastic‐large‐cell(last accessed: 13 December 2019).
3. Brentuximab vedotin
4. Variability in the Expression of Immunohistochemical Markers: Implications for Biomarker Interpretation in Cutaneous T-Cell Lymphoma
5. Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Extravasation of monoclonal antibodies commonly used in oncology: Classification, management and the role of the pharmacist;Journal of Oncology Pharmacy Practice;2023-05-24
2. Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation;Dermatologic Therapy;2022-08-14
3. Intraindividual variability of CD30 expression in mycosis fungoides –implications for diagnostic evaluation and therapy;Histopathology;2022-05-04
4. Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy;Cancers;2021-12-05
5. Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report;International Journal of Dermatology;2021-08-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3